You are here

Inflammation as a risk factor for atrial fibrillation.

TitleInflammation as a risk factor for atrial fibrillation.
Publication TypeJournal Article
Year of Publication2003
AuthorsAviles, RJ, Martin, DO, Apperson-Hansen, C, Houghtaling, PL, Rautaharju, P, Kronmal, RA, Tracy, RP, Van Wagoner, DR, Psaty, BM, Lauer, MS, Chung, MK
JournalCirculation
Volume108
Issue24
Pagination3006-10
Date Published2003 Dec 16
ISSN1524-4539
KeywordsAged, Atrial Fibrillation, C-Reactive Protein, Cross-Sectional Studies, Female, Humans, Inflammation, Longitudinal Studies, Male, Risk Factors
Abstract<p><b>BACKGROUND: </b>The presence of systemic inflammation determined by elevations in C-reactive protein (CRP) has been associated with persistence of atrial fibrillation (AF). The relationship between CRP and prediction of AF has not been studied in a large population-based cohort.</p><p><b>METHODS AND RESULTS: </b>CRP measurement and cardiovascular assessment were performed at baseline in 5806 subjects enrolled in the Cardiovascular Health Study. Patients were followed up for a mean of 6.9+/-1.6 (median 7.8) years. AF was identified by self-reported history and ECGs at baseline and by ECGs and hospital discharge diagnoses at follow-up. Univariate and multivariate analyses were used to assess CRP as a predictor of baseline and future development of AF. At baseline, 315 subjects (5%) had AF. Compared with subjects in the first CRP quartile (<0.97 mg/L), subjects in the fourth quartile (>3.41 mg/L) had more AF (7.4% versus 3.7%, adjusted OR 1.8, 95% CI 1.2 to 2.5; P=0.002). Of 5491 subjects without AF at baseline, 897 (16%) developed AF during follow-up. Baseline CRP predicted higher risk for developing future AF (fourth versus first quartile adjusted hazard ratio 1.31, 95% CI 1.08 to 1.58; P=0.005). When treated as a continuous variable, elevated CRP predicted increased risk for developing future AF (adjusted hazard ratio for 1-SD increase, 1.24; 95% CI 1.11 to 1.40; P<0.001).</p><p><b>CONCLUSIONS: </b>CRP is not only associated with the presence of AF but may also predict patients at increased risk for future development of AF.</p>
DOI10.1161/01.CIR.0000103131.70301.4F
Alternate JournalCirculation
PubMed ID14623805
Grant ListHL-65412 / HL / NHLBI NIH HHS / United States
N01 HC-15103 / HC / NHLBI NIH HHS / United States
N01-HC-35129 / HC / NHLBI NIH HHS / United States
N01-HC-85079 / HC / NHLBI NIH HHS / United States
N01-HC-85080 / HC / NHLBI NIH HHS / United States
N01-HC-85081 / HC / NHLBI NIH HHS / United States
N01-HC-85082 / HC / NHLBI NIH HHS / United States
N01-HC-85083 / HC / NHLBI NIH HHS / United States
N01-HC-85084 / HC / NHLBI NIH HHS / United States
N01-HC-85085 / HC / NHLBI NIH HHS / United States
N01-HC-85086 / HC / NHLBI NIH HHS / United States